Sit Investment Associates Inc Ocugen, Inc. Transaction History

Sit Investment Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$1.66 - $15.81 $124,500 - $1.19 Million	-75,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$0.2 - $0.72 $15,000 - $54,000	75,000 New	75,000 $23,000
Q3 2020 Nov 12, 2020	SELL	$0.2 - $0.72 $15,000 - $54,000	-75,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.22 - $0.46 $16,500 - $34,500	75,000 New	75,000 $17,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $195M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.